Correction to: intravitreal aflibercept for diabetic macular edema in real‑world clinical practice in japan: 24‑month outcomes

HIGHLIGHTS

• who: Masahiko Sugimoto from the Department of Ophthalmology, Mie University Graduate School of Medicine, u2011, Edobashi, Tsu, Mie, u20118507, Japan have published the paper: Correction to: Intravitreal aflibercept for diabetic macular edema in realu2011world clinical practice in Japan: 24u2011month outcomes, in the Journal: (JOURNAL)

SUMMARY

Data are not shown for eight patients whose previous treatment status was unknown. (b) CRTs (μm) and numbers of patients during the 24-month study period. Data are not shown for three patients whose previous treatment status was unknown. BCVA best-corrected visual acuity; BL baseline; CRT​central . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.